EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expanding the Spectrum of Canine Diffuse Large B‐Cell Lymphoma Genetic Aberrations Through Whole Genome Sequencing Analysis

Antonella Fanelli iD, Eugenio Mazzone, Diana Giannuzzi, Laura Marconato iD, Luca Aresu iD

Veterinary and Comparative Oncology · 2025

DOI: 10.1111/vco.13059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, 2025. Verfasst von Antonella Fanelli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Sciences, University of Turin, Grugliasco, Turin, Italy. Hauptthemen laut MEDLINE: Dog Diseases, Lymphoma, Large B-Cell, Diffuse. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diffuse large B‐cell lymphoma (DLBCL) is one of the most prevalent haematological malignancies in both humans and dogs, characterised in both species by significant clinical heterogeneity and limited prognostic predictability. With the introduction of next‐generation sequencing (NGS) technologies in veterinary medicine over the past decade, researchers have begun to elucidate the molecular basis of canine DLBCL (cDLBCL); however, much of the clinical heterogeneity associated with this tumour remains unexplained. In this study, we performed whole genome sequencing on 10 cDLBCL cases, all treated with chemo‐immunotherapy, which exhibited similar clinico‐pathological features but markedly different outcomes. Cases were classified as “poor” or “good” responders based on whether their lymphoma‐specific survival fell below or above the cohort's median. Protein‐coding variants and copy number aberrations unique to poor or good responders revealed novel candidate genes not previously identified in cDLBCL studies, while splicing, untranslated regions, and intronic variants were detected in genes already known to be recurrently mutated. In conclusion, our investigation has broadened the spectrum of potentially pathogenic variants implicated in cDLBCL, though further studies with larger cohorts are necessary to validate these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dog DiseasesLymphoma, Large B-Cell, DiffuseDogsAnimalsWhole Genome SequencingMaleFemaleHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

DLBCLdiffuse large B‐cell lymphomadogprognosiswhole genome sequencing

Autor:innen und Institutionen

  • Department of Veterinary Sciences, University of Turin, Grugliasco, Turin, Italy.
  • Department of Agronomy, Food, Natural Resources, Animals and Environment (DAFNAE), University of Padua, Legnaro, Padua, Italy.
  • Department of Veterinary Medical Sciences, University of Bologna, Ozzano dell'Emilia, Bologna, Italy.

ORCID-Profile: Antonella Fanelli, Laura Marconato, Luca Aresu

Zitieren

APA

Fanelli, A., Mazzone, E., Giannuzzi, D., Marconato, L., & Aresu, L. (2025). Expanding the Spectrum of Canine Diffuse Large B‐Cell Lymphoma Genetic Aberrations Through Whole Genome Sequencing Analysis. Veterinary and Comparative Oncology. https://doi.org/10.1111/vco.13059

Vancouver

Fanelli A, Mazzone E, Giannuzzi D, Marconato L, Aresu L. Expanding the Spectrum of Canine Diffuse Large B‐Cell Lymphoma Genetic Aberrations Through Whole Genome Sequencing Analysis. Veterinary and Comparative Oncology. 2025. doi:10.1111/vco.13059

BibTeX
@article{Fanelli2025,
  author = {Fanelli, Antonella and Mazzone, Eugenio and Giannuzzi, Diana and Marconato, Laura and Aresu, Luca},
  title = {Expanding the Spectrum of Canine Diffuse Large B‐Cell Lymphoma Genetic Aberrations Through Whole Genome Sequencing Analysis},
  journal = {Veterinary and Comparative Oncology},
  year = {2025},
  doi = {10.1111/vco.13059}
}
Kostenlos starten →